Tecogen Inc. (TGEN) shareholders
Close on Nov 17, 2026Market cap $54.94MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Portolan Capital Management, LLC Joint filing with George McCabe (5.19%) | 1,552,232 | 5.19% | 13G (passive) | Jun 3, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TGEN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Portolan Capital Management, LLC | 1,551,113 | 5.14% | $8.10M | +1,107,558 | 0.30% |
| Vanguard Capital Management LLC | 788,670 | 2.61% | $4.12M | +18,706 | 0.00% |
| Bard Associates Inc | 682,221 | 2.26% | $3.56M | −6,088 | 0.79% |
| Clear Harbor Asset Management, LLC | 650,000 | 2.15% | $3.39M | – | 0.21% |
| Herald Investment Management Ltd | 420,000 | 1.39% | $2.19M | – | 0.30% |
| Gratia Capital, LLC | 388,660 | 1.29% | $2.03M | New | 1.23% |
| UBS Group AG | 363,049 | 1.20% | $1.90M | +43,213 | 0.00% |
| Meros Investment Management, LP | 353,487 | 1.17% | $1.85M | +61,782 | 0.59% |
| Palisades Investment Partners, LLC | 323,090 | 1.07% | $1.69M | −10,817 | 0.48% |
| Susquehanna International Group, Llp | 315,831 | 1.05% | $1.65M | +206,374 | 0.00% |
| Morgan Stanley | 301,695 | 1.00% | $1.57M | +224,959 | 0.00% |
| Raymond James Financial Inc | 290,260 | 0.96% | $1.52M | +104,466 | 0.00% |
| BlackRock, Inc. | 251,464 | 0.83% | $1.31M | +66,685 | 0.00% |
| Citadel Advisors LLC | 242,276 | 0.80% | $1.26M | +94,804 | 0.00% |
| Huntleigh Advisors, Inc. | 220,074 | 0.73% | $1.15M | New | 0.16% |
| Heartland Advisors Inc | 182,100 | 0.60% | $950.56K | New | 0.04% |
| Geode Capital Management, LLC | 180,870 | 0.60% | $944.80K | −11,132 | 0.00% |
| Thompson Davis & Co., Inc. | 144,840 | 0.48% | $755.86K | +45,840 | 0.45% |
| New York State Common Retirement Fund | 137,200 | 0.45% | $716.18K | – | 0.00% |
| Gsa Capital Partners Llp | 126,451 | 0.42% | $660.00K | +32,281 | 0.04% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 69 | 9M | 31.4% | 20 / 18 | 15 / 13 | 3M | 2M |
| Q1 2026 | 62 | 8M | 25.8% | 15 / 16 | 19 / 17 | 2M | 1M |
| Q4 2025 | 65 | 8M | 25.2% | 15 / 23 | 17 / 19 | 1M | 1M |
| Q3 2025 | 70 | 8M | 25.6% | 42 / 15 | 6 / 2 | 4M | 0M |
| Q2 2025 | 30 | 4M | 13.0% | 29 / 1 | 0 / 0 | 4M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2023 | 1 | 0M | 1.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 1 | 0M | 1.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2023 | 1 | 0M | 1.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2023 | 1 | 0M | 1.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2022 | 1 | 0M | 1.1% | 0 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
18 funds held TGEN in Q2 2026, 44% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of TGEN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Strategic Advisers U.S. Total Stock Fund | 748,390 | 2.48% | $4.65M | 0.00% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 579,798 | 1.92% | $3.03M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 189,154 | 0.63% | $987.38K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 87,813 | 0.29% | $545.32K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 62,527 | 0.21% | $326.39K | 0.02% | Jun 30, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 46,949 | 0.16% | $245.07K | 0.00% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 33,048 | 0.11% | $172.51K | 0.12% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 28,880 | 0.10% | $179.34K | 0.00% | May 31, 2026 |
| Acuitas US Microcap Fund | 25,834 | 0.09% | $134.85K | 0.11% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 25,754 | 0.09% | $159.93K | 0.00% | May 31, 2026 |
| Gabelli Global Mini Mites Fund | 20,000 | 0.07% | $104.40K | 0.39% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 11,037 | 0.04% | $57.61K | 0.00% | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 8,681 | 0.03% | $45.31K | 0.00% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 5,837 | 0.02% | $19.38K | 0.00% | Jul 31, 2026 |
| U.S. Core Equity 1 Portfolio | 5,324 | 0.02% | $17.68K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Abinand Rangesh | Chief Executive Officer, Director | 241,274 | 0.80% | Sep 8, 2026 |
| John Kimball Whiting IV | General Counsel & Secretary | 41,954 | 0.14% | Sep 8, 2026 |
| Robert Panora | COO and President | 72,194 | 0.24% | Sep 8, 2026 |
| Roger P. Deschenes | Chief Financial Officer | 81,975 | 0.27% | Sep 8, 2026 |
| Stephen Lafaille | VP of Business Development | 41,389 | 0.14% | Sep 8, 2026 |
| Ahmed Ghoniem | Director | 12,723 | 0.04% | Jun 30, 2026 |
| Susan B. Hirsch | Director | 265,416 | 0.88% | Jun 30, 2026 |
| John M. Albertine | Director | – | – | Jun 30, 2026 |
| Earl Lewis | Director | 1,646,006 | 5.45% | Jun 30, 2026 |
| Angelina Galiteva | Director | 50,000 | 0.17% | Jun 30, 2026 |
| John Hatsopoulos | Director | 1,114,513 | 3.69% | Mar 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Stephen Lafaille VP of Business Development | Jun 26, 2026 | Award | +29,013 | – | – | 41,389 |
| Roger P. Deschenes Chief Financial Officer | Jun 26, 2026 | Award | +29,013 | – | – | 81,975 |
| Robert Panora COO and President | Jun 26, 2026 | Award | +9,671 | – | – | 72,194 |
| John Kimball Whiting IV General Counsel & Secretary | Jun 26, 2026 | Award | +19,342 | – | – | 41,954 |
| Abinand Rangesh Chief Executive Officer, Director | Jun 26, 2026 | Award | +174,081 | – | – | 241,274 |
| Abinand Rangesh Chief Executive Officer, Director | Jun 26, 2026 | Award | +174,081 | – | – | 174,081 |
| Stephen Lafaille VP of Business Development | Jun 26, 2026 | Award | +29,013 | – | – | 29,013 |
| John Kimball Whiting IV General Counsel & Secretary | Jun 26, 2026 | Award | +19,342 | – | – | 19,342 |
| Roger P. Deschenes CAO | Jun 26, 2026 | Award | +29,013 | – | – | 29,013 |
| Robert Panora COO and President | Jun 26, 2026 | Award | +9,671 | – | – | 9,671 |
| Ahmed Ghoniem Director | Apr 24, 2026 | Buy | +12,723 | $0.79 | $10.05K | 12,723 |
| Susan B. Hirsch Director | Apr 13, 2026 | Buy | +5,000 | $3.73 | $18.65K | 265,416 |
| Earl Lewis Director | Mar 27, 2026 | Buy | +5,000 | $2.52 | $12.60K | 1,011,006 |
| Susan B. Hirsch Director | Mar 27, 2026 | Buy | +10,000 | $2.54 | $25.40K | 260,416 |
| Earl Lewis Director | Mar 26, 2026 | Buy | +5,000 | $2.88 | $14.40K | 1,006,006 |
| John Kimball Whiting IV General Counsel & Secretary | Mar 23, 2026 | Buy | +10,000 | $2.38 | $23.80K | 22,612 |
| Abinand Rangesh Chief Executive Officer, Director | Mar 20, 2026 | Buy | +3,000 | $2.30 | $6.90K | 67,193 |
| Roger P. Deschenes CAO | Mar 20, 2026 | Buy | +10,000 | $2.23 | $22.30K | 52,962 |
| John Hatsopoulos Director | Mar 20, 2026 | Option exercise | +50,000 | $0.88 | $44.00K | 1,038,951 |
| Stephen Lafaille VP of Business Development | Jul 24, 2025 | Award | +11,976 | – | – | 12,376 |
| John Kimball Whiting IV General Counsel & Secretary | Jul 24, 2025 | Award | +11,976 | – | – | 12,612 |
| Roger P. Deschenes CAO | Jul 24, 2025 | Award | +17,964 | – | – | 42,962 |
| Abinand Rangesh Chief Executive Officer, Director | Jul 24, 2025 | Award | +53,892 | – | – | 64,193 |
| Robert Panora COO and President | Jun 24, 2025 | Sale | −900 | $6.86 | $6.17K | 62,523 |
| Robert Panora COO and President | Jun 23, 2025 | Sale | −31,800 | $6.36 | $202.25K | 63,423 |
| Stephen Lafaille VP of Business Development | Jun 23, 2025 | Option exercise | +10,000 | $1.10 | $11.00K | 10,400 |
| Stephen Lafaille VP of Business Development | Jun 23, 2025 | Sale | −10,000 | $7.25 | $72.50K | 400 |
| Robert Panora COO and President | Jun 18, 2025 | Sale | −13,000 | $5.03 | $65.39K | 95,223 |
| Robert Panora COO and President | Jun 16, 2025 | Option exercise | +52,500 | $1.10 | $57.75K | 108,223 |
| Robert Panora COO and President | Jun 16, 2025 | Option exercise | +30,000 | $0.71 | $21.30K | 55,723 |
| Robert Panora COO and President | Jun 16, 2025 | Option exercise | +12,723 | $0.79 | $10.05K | 25,723 |
| Robert Panora COO and President | Jun 16, 2025 | Option exercise | +12,723 | $0.79 | $10.05K | 82,723 |
| Robert Panora COO and President | Jun 16, 2025 | Option exercise | +52,500 | $1.10 | $57.75K | 165,223 |
| Robert Panora COO and President | Jun 16, 2025 | Option exercise | +30,000 | $0.71 | $21.30K | 112,723 |
| Stephen Lafaille VP of Business Development | Jun 6, 2025 | Sale | −25,000 | $5.98 | $149.50K | 400 |
| Stephen Lafaille VP of Business Development | Jun 6, 2025 | Option exercise | +25,000 | $1.10 | $27.50K | 25,400 |
| Robert Panora COO and President | Jun 4, 2025 | Sale | −31,000 | $5.00 | $155.00K | 13,000 |
| Stephen Lafaille VP of Business Development | Jun 4, 2025 | Sale | −15,000 | $5.00 | $75.00K | 400 |
| Stephen Lafaille VP of Business Development | Jun 4, 2025 | Option exercise | +15,000 | $0.71 | $10.65K | 15,400 |
| Robert Panora COO and President | Jun 3, 2025 | Sale | −26,000 | $4.69 | $121.94K | 44,000 |
| Stephen Lafaille VP of Business Development | Jun 3, 2025 | Sale | −10,000 | $4.88 | $48.80K | 400 |
| Stephen Lafaille VP of Business Development | Jun 3, 2025 | Option exercise | +10,000 | $0.71 | $7.10K | 10,400 |
| Robert Panora COO and President | May 27, 2025 | Option exercise | +70,000 | $0.71 | $49.70K | 70,000 |
| Earl Lewis Director | May 6, 2025 | Option exercise | +6,250 | $1.10 | $6.88K | 1,001,006 |
| Earl Lewis Director | May 6, 2025 | Option exercise | +15,000 | $1.75 | $26.25K | 982,256 |
| Earl Lewis Director | May 6, 2025 | Option exercise | +12,500 | $1.20 | $15.00K | 994,756 |
| Earl Lewis Director | May 1, 2025 | Other | +240,256 | $2.14 | $514.15K | 967,256 |
| Stephen Lafaille VP of Business Development | Mar 3, 2025 | Buy | +400 | $2.50 | $1.00K | 400 |
| Earl Lewis Director | Nov 22, 2024 | Option exercise | +100,000 | $0.71 | $71.00K | 727,000 |
| Earl Lewis Director | Nov 22, 2024 | Buy | +100,000 | $0.71 | $71.00K | 737,000 |
| John Hatsopoulos Director | Sep 27, 2024 | Buy | +10,000 | $0.84 | $8.40K | 988,951 |
| John Hatsopoulos Director | Sep 25, 2024 | Buy | +10,000 | $0.86 | $8.60K | 978,951 |
| John Hatsopoulos Director | Aug 19, 2024 | Buy | +10,000 | $0.90 | $9.00K | 968,951 |
| Earl Lewis Director | Jul 15, 2024 | Buy | +10,000 | $0.68 | $6.80K | 625,000 |
| Earl Lewis Director | Jul 15, 2024 | Buy | +10,000 | $0.68 | $6.80K | 635,000 |
| Earl Lewis Director | Jul 15, 2024 | Buy | +10,000 | $0.68 | $6.80K | 625,000 |
| John Hatsopoulos Director | Jul 10, 2024 | Buy | +22,466 | $0.65 | $14.60K | 958,951 |
| John Hatsopoulos Director | May 29, 2024 | Buy | +10,000 | $0.80 | $8.00K | 935,220 |
| John Hatsopoulos Director | May 28, 2024 | Buy | +1,265 | $0.80 | $1.01K | 936,485 |
| John Hatsopoulos Director | May 24, 2024 | Buy | +8,735 | $0.80 | $6.99K | 925,220 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Tecogen's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,063 shares on Sep 9, 2026 over the last 90 days.
See a number that looks wrong?